Test Your Knowledge About the Diagnosis of Alpha-1 Antitrypsin Deficiency Test Your Knowledge About the Symptoms of Patients With AATD Test Your Knowledge About the Prognosis of Patients With AATD ...
Between 1970 and 1995, the incidence of new NHL cases increased. Between 2007 and 2016, new cases declined by approximately 0.9% per year, and mortality from NHL decreased by 2.2% per year. 3 ...
Rare Disease Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...
In MG, patients should typically receive vaccinations before initiating complement inhibitor therapy to avoid unnecessary antibiotic exposure. Experts in Germany, Austria, and Switzerland issued ...
The phase 3 REVEAL study of iodine-124 evuzamitide in 170 adults with suspected cardiac amyloidosis met its primary endpoints of sensitivity and specificity based on visual interpretation. The ...
After the enzyme-linked immunosorbent assay was added to the solid phase red cell adherence test, the detection rate of anti-CD36 increased about 15-fold. Platelet antibodies that may lead to fetal ...
The trial is running in 142 locations worldwide, including the US, and is expected to be completed in August 2026. The double-blind, placebo-controlled phase 3 study enrolled and randomized 1432 ...
The FDA granted Fast Track Designation to coramitug for ATTR-CM as it advances in the ongoing phase 3 CLEOPATTRA trial. The US Food and Drug Administration (FDA) has granted Fast Track Designation to ...
Participants in cohort 1 (aged 6-17 years) demonstrated lower plasma exposure compared with levels previously observed in healthy adult volunteers. The phase 1/2 ELEVATE-44-201 trial evaluating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results